Nidan Laboratories and Healthcare Limited
Promoter holding in Nidan Laboratories and Healthcare Limited has stayed unchanged at 57.04% for the last 8 quarters on record (since Mar 2024).
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Sep '26 | 57.04%=0.00 | 42.96%=0.00 |
| Jun '26 | 57.04%=0.00 | 42.96%=0.00 |
| Mar '26 | 57.04%=0.00 | 42.96%=0.00 |
| Dec '25 | 57.04%=0.00 | 42.96%=0.00 |
| Sep '25 | 57.04% | 42.96% |
| Jun '25 | No filing on record | |
| Mar '25 | 57.04% | 42.96% |
| Dec '24 | No filing on record | |
| Sep '24 | 57.04% | 42.96% |
| Jun '24 | No filing on record | |
| Mar '24 | 57.04% | 42.96% |
Trend
- Over a longer period, promoter holding went from 71.22% in Sep 2021 to 57.04% in Sep 2026, down 14.18 points.
Compared with similar companies
Promoter holding in Nidan Laboratories and Healthcare Limited is lower than 53% of companies in India.
Questions
What is Nidan Laboratories and Healthcare Limited's promoter holding?
Promoters held 57.04% of Nidan Laboratories and Healthcare Limited as of 30 Sep 2026, and the public held 42.96%.
Has Nidan Laboratories and Healthcare Limited's promoter holding increased?
No, it was unchanged in the quarter to Sep 2026.
Are any promoter shares of Nidan Laboratories and Healthcare Limited pledged?
No promoter shares are recorded as pledged.
How has Nidan Laboratories and Healthcare Limited's promoter holding changed over the years?
Over a longer period, promoter holding went from 71.22% in Sep 2021 to 57.04% in Sep 2026, down 14.18 points.
How does Nidan Laboratories and Healthcare Limited's promoter holding compare with similar companies?
Promoter holding in Nidan Laboratories and Healthcare Limited is lower than 53% of companies in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.